Metabolomics Uncovers Biomarkers for PCOS Diagnosis and Therapy – JMSACL
JMSACL (Journal of Mass Spectrometry and Advances in the Clinical Lab) shared a post on LinkedIn:
“Source: (Journal of ovarian research)
Study on PCOS via mass spectrometry metabolomics identified 49 serum metabolites, with 39 upregulated and 10 downregulated. Key findings include altered lipid and amino acid metabolism, revealing candidate biomarkers for diagnosis and therapy. Metabolic pathways affected include sphingolipid metabolism.”
Title: Mass spectrometry-based untargeted metabolomics study of polycystic ovary syndrome
Authors: Ömer Faruk Özer, Ayşe Zeynep İbrahimoğlu, Ayşe Zehra Gül, Metin Demirel, Seda Ateş, Havva Sevde Taha, Merve İbrahimoğlu, Şahabettin Selek
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Nov 2, 2026, 17:08Elena Milner: The 2nd Class of the School of Embryology Is Already in Full Swing
-
Nov 2, 2026, 17:05November Is National Diabetes Month – PCOS Awareness Association
-
Nov 2, 2026, 17:04Thanos Papathanasiou: Are We Preparing Patients for the IVF Cycle, or for the IVF Journey?
-
Nov 2, 2026, 17:02Anna Morales: Why Is It So Hard to Build in Women’s Health?
-
Nov 2, 2026, 16:59Rickard Ericsson: Honored to Take on the Role of Interim CEO of the Vitrolife Group
-
Nov 2, 2026, 16:56Mohammed Nasur: 1 Small Simulation, A Bigger Purpose
-
Nov 2, 2026, 16:54Carlos Guerrero: Presenting Our Latest Research on AI and Embryo Assessment at ASRM 2026
-
Nov 2, 2026, 16:52Sarah Lewen: My 1st ASRM Is Officially Complete
-
Nov 2, 2026, 16:49Jemma Garratt: Taking on the Role of Kind IVF and Data Science Manager at London Women’s Clinic